Linagliptin impurity 16(1955514-80-3)
- Name: Linagliptin impurity 16
- Synonyms:Ligliptin Impurity CD10925;Linagliptin Imp.CD10925;Linagliptin N-Aminocarbonyl Impurity;Urea, N-[1-[7-(2-butyn-1-yl)-2,3,6,7-tetrahydro-3-methyl-1-[(4-methyl-2-quinazolinyl)methyl]-2,6-dioxo-1H-purin-8-yl]-3-piperidinyl]-;Linagliptin Impurity 106;8-[(3R)-3-Aminocarbonylamino-1-piperidinyl]-7-(2-butyn-1-yl)-3,7-dihydro-3-methyl-1-[(4-methyl-2-quinazolinyl)methyl]-1H-purine-2,6-dione;{1-[7-(but-2-yn-1-yl)-3-methyl-1-[(4-methylquinazolin-2-yl)methyl]-2,6-dioxo-2,3,6,7-tetrahydro-1H-purin-8-yl]piperidin-3-yl}urea;1-(1-(7-(But-2-yn-1-yl)-3-methyl-1-((4-methylquinazolin-2-yl)methyl)-2,6-dioxo-2,3,6,7-tetrahydro-1H-purin-8-yl)piperidin-3-yl)urea (Linagliptin impurity)
- Molecular Formula:C26H29N9O3
- Molecular Weight:515.57
- CAS Registry Number:1955514-80-3
- EINECS:
- Melting Point:
- Water Solubility:
Other Product
- 1955514-55-2/2H-Pyran-3-amine, 2-(1-ethyl-1H-pyrazol-4-yl)tetrahydro-, hydrochloride (1:2)
- 1955514-56-3/2-Piperidinone, 5-amino-1-methyl-6-(1-methyl-1H-imidazol-5-yl)-, hydrochloride (1:1)
- 1955514-57-4/Imidazo[1,2-a]pyrazine-2-carboxamide, N-cyclopropyl-5,6,7,8-tetrahydro-
- 1955514-58-5/4-Thiomorpholinecarboxylic acid, 3-(2-aminoethyl)-, 1,1-dimethylethyl ester, hydrochloride (1:1)
- 1955514-60-9/2-Pyrrolidinone, 4-(4-piperidinyl)-, hydrochloride (1:1)
- 1955514-62-1/Cyclohexanemethanol, 3-(aminomethyl)-, hydrochloride (1:1)
- 1955514-63-2/3-Furanamine, tetrahydro-2-(6-methoxy-3-pyridinyl)-, hydrochloride (1:2)
- 1955514-64-3/1,2-Benzenediamine, 4-(1-methylethyl)-, hydrochloride (1:1)
- 1955514-65-4/3-[(4-Methoxypyrrolidin-2-yl)methoxy]pyridine dihydrochloride
- 1955514-69-8/3-Pyrrolidinecarboxylic acid, 1-ethyl-2-(1-methyl-1H-imidazol-2-yl)-5-oxo-
- 1955514-70-1/2-Fluorocyclohexan-1-amine hydrobromide
- 1955514-71-2/3-ethyl-5-(5,6,7,8-tetrahydroimidazo[1,2-a]pyrazin-2-yl)-1,2,4-oxadiazole
- 1955514-72-3/Cyclopenta[c]pyrrole, octahydro-3a-[3-(2-pyrazinyl)-1,2,4-oxadiazol-5-yl]-
- 1955514-73-4/Benzoic acid, 5-chloro-3-(fluorosulfonyl)-2-methyl-
- 1955514-74-5/N-methyl-1-(6-(thiophen-3-yl)-[1,2,4]triazolo[4,3-b]pyridazin-3-yl)methanamine
- 1955514-75-6/4-Piperidinemethanamine, N-(1-methylcyclohexyl)-, hydrochloride (1:1)
- 1955514-76-7/4-Isoquinolinecarboxylic acid, 1,2-dihydro-2-(3-methylbutyl)-1-oxo-
- 1955514-78-9/Cyclopenta[c]pyrrole, octahydro-3a-[3-(phenylmethyl)-1,2,4-oxadiazol-5-yl]-, hydrochloride (1:1)
- 1955514-79-0/1H-1,2,4-Triazole, 5-(4-methoxy-2-pyrrolidinyl)-3-methyl-, hydrochloride (1:2)
- 1955514-80-3/Linagliptin impurity 16
- 1955514-82-5/2-(1H-pyrrolo[2,3-c]pyridin-3-yl)ethan-1-amine hydrochloride
- 1955514-83-6/Benzoic acid, 3-chloro-5-(fluorosulfonyl)-4-methyl-
- 1955514-87-0/1-[(3,4-dimethoxyphenyl)methyl]-3-methyl-1H-pyrazol-5-amine hydrochloride
- 1955514-89-2/2-Pyrimidineacetic acid, 4-propoxy-, ethyl ester
- 1955514-90-5/3-Pyrrolidinol, 4-[ethyl[(5-methyl-1,3,4-oxadiazol-2-yl)methyl]amino]-
- 1955514-92-7/(2,2-difluoro-3,3-dimethylcyclopropyl)methanamine hydrochloride
- 1955514-93-8/methyl 2-(3-methoxyphenyl)-2-(methylamino)acetate hydrochloride
- 1955514-97-2/1,2-Pyrrolidinedicarboxylic acid, 2-(methoxymethyl)-, 1-(1,1-dimethylethyl) ester
- 1955514-98-3/6,7-dihydro-5H-benzo[7]annulen-2-amine hydrochloride
- 1955514-99-4/ethyl 2-oxa-6-azaspiro[3.4]octane-8-carboxylate hemioxalate